# TAIC FOLFOX for Locally Advanced G/GEJA

> **NCT07655024** · PHASE2 · RECRUITING · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 31 (estimated)

## Conditions studied

- Gastric Cancer (Diagnosis)
- Gastroesophageal Junction Adenocarcinoma

## Interventions

- **PROCEDURE:** TAIC
- **DRUG:** FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)

## Key facts

- **NCT ID:** NCT07655024
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655024, "TAIC FOLFOX for Locally Advanced G/GEJA". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*